FDA
-
-
-
-
-
-
-
Sanofi to Acquire Translate Bio; Advances Deployment of mRNA Technology across Vaccines and Therapeutics Development
-
-
-
-
-
-
-
Translate Bio Announces First Quarter 2021 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
Translate Bio Announces Publication of Preclinical Results of COVID-19 mRNA Vaccine Candidate MRT5500 in npj Vaccines
-
-
-
-
-
-
-
Sanofi (SNY) and Translate Bio (TBIO) Initiate Phase 1/2 Clinical Trial of mRNA COVID-19 Vaccine Candidate
-
-
-
-
-
-
-
Translate Bio (TBIO) Announces Timing of Interim Results from mRNA Therapeutic Clinical Trial in Patients with Cystic Fibrosis; Data Expected in Early Q2 2021
-
-
-
-
-
-
-
Translate Bio Highlights mRNA Platform Potential for the Treatment of Cystic Fibrosis (CF) at the 34th Annual North American Cystic Fibrosis Conference
-
-
-
-
-
-
-
Translate Bio Announces Closing of Expanded Collaboration and Licensing Agreement with Sanofi Pasteur to Develop mRNA Vaccines for All Infectious Diseases
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

